Clinical Trial Update: A Novel Combination Oral Agent to Treat Acne Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial evaluating a novel oral combination therapy for acne vulgaris by Nexgen Dermatologics, with the current status u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Snippet

Sponsor: Nexgen Dermatologics, Inc. | Conditions: ACNE VULGARIS | Phase 1, Phase 2 | Status: UNKNOWN